 Home > Active Ingredient News > Infection > Xerava (eravacycline) to treat complex celiac infections: a Phase III clinical trial in China is to be conducted.

Xerava (eravacycline) to treat complex celiac infections: a Phase III clinical trial in China is to be conducted.

 Last Update: 2020-09-20
 Source: Internet
 Author: User

Tags

new china martinsburg

chief people officer

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Infections in the abdominal cavity are usually caused by inflammation or rupture of the gastrointestinal tract.
, celiac infections can also come from the urinary tract or the female reproductive tract.
celiac infections are usually caused by a variety of microorganisms and can cause abdominal abscesses or secondary perititis, which can be widespread or limited (cellulitis).
pharmaceutical company Everest Pharmaceuticals recently announced that it has completed its Phase III clinical trial of eravacycline to treat patients with complex cIAI infections in China.
Xerava (eravacycline) is a new, fully synthetic broad-spectrum gastrointestinal cyclin.
in two previous key global studies, Xerava has good tolerance in cIAI patients and is statistically no less statistically inferior to two widely used drugs (ertapenem and meropenem).
two studies led to Xerava's approval in the United States, the European Union and Singapore.
results of the China trial are expected to be released in the fourth quarter of 2020 and will support Everest Pharmaceuticals in submitting applications for new drugs in China.
First China Phase III clinical trial is an important milestone for Everest Medicines," said Sunny Zhu, chief medical officer for Infectious Diseases at Everest Medicines.
Xerava represents an important new treatment that can be used to deal with complex infections."
.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Phenol CAS NO. 108-95-2 Factory Supply 99% High Quality liquid

CAS No.: 108-95-2

Industrial Grade

$1-1.2/KG FOB

High Quality Trichloroisocyanuric acid 90% powder tabella particle 87-90-1 -Shaanxi Dideu Medichem Co.Ltd

CAS No.: 87-90-1

Chemical Grade

$1/KG FOB

OXITETRACICLINA BASE

CAS No.: 6153-64-6

Industrial Grade

$1-1.02/MT FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.